Evaluation of serum anti-nuclear antibody among women with PCOS: a hospital based single center cross sectional study

References

• Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31:2841–2855.
   PubMed Web of Science ®Google Scholar
• Nair MKC, Pappachan P, Balakrishnan S, et al. Menstrual irregularity and polycystic ovarian syndrome among adolescent girls – a 2 year follow-up study. Indian J Pediatr. 2012;79(Suppl S73):69.
   Web of Science ®Google Scholar
• Nidhi R, Padmalatha V, Nagarathna R, et al. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011;24:223–227.
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–800.
   PubMed Web of Science ®Google Scholar
• Shabir I, Ganie MA, Zargar MA, et al. Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India. Indian J Endocr Metab. 2014;18:364–369.
   PubMedGoogle Scholar
• Ganie MA, Dhingra A, Nisar S, et al. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent. Fertil Steril. 2016;105:194–201.e1–3.
   PubMed Web of Science ®Google Scholar
• Ibanez L, Oberfield SE, Witchel S, et al. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017;88:371–395.
   PubMed Web of Science ®Google Scholar
• Patlolla S, Vaikkakara S, Sachan A, et al. Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2017;25:1–5.
   Google Scholar
• Petrikova J, Lazurova I, Yehuda S. Polycystic ovary syndrome and autoimmunity. Eur J Intern Med. 2010;21:369–371.
   PubMed Web of Science ®Google Scholar
• Barland P, Lipstein E. Selection and use of laboratory tests in the rheumatic diseases. Am J Med. 1996;100:16S–23S.
   PubMed Web of Science ®Google Scholar
• Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev. 1997;18:107–134.
   PubMed Web of Science ®Google Scholar
• Ulukus M, Arici A. Immunology of endometriosis. Minerva Ginecol. 2005;57:237–248.
   PubMedGoogle Scholar
• Ganie MA, Marwaha RK, Aggarwal R, et al. High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study. Eur J Endocrinol. 2010;162:1117–1122.
   PubMed Web of Science ®Google Scholar
• Nisar S, Shah PA, Kuchay MS, et al. Association of polycystic ovary syndrome and Grave's disease: is autoimmunity the link between the two diseases. Indian J Endocr Metab. 2012;16:982–986.
   PubMedGoogle Scholar
• Hefler-Frischmuth K, Walch K, Huebl W, et al. Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril. 2010;93:2291–2294.
   PubMed Web of Science ®Google Scholar
• Reimand K, Talja I, Metsküla K, et al. Autoantibody studies of female patients with reproductive failure. J Reprod Immunol. 2001;51:167–176.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47.
   PubMed Web of Science ®Google Scholar
• Ganie MA, Khurana ML, Eunice M, et al. Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labelled study. J Clin Endocrinol Metab. 2004;89:4655.
   Web of Science ®Google Scholar
• Cianci A, Panella M, Fichera M, et al. D-chiro-inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS. Gynecol Endocrinol. 2015;31:483–486.
   PubMed Web of Science ®Google Scholar
• Piomboni P, Focarelli R, Capaldo A, et al. Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin. J Assist Reprod Genet. 2014;31:1269–1276.
   PubMed Web of Science ®Google Scholar
• Ciotta L, De Leo V, Galvani F, et al. Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia. Hum Reprod. 1999;14:2951–2958.
   PubMed Web of Science ®Google Scholar
• Baillargeon JP, Iuorno MJ, Jakubowicz DJ, et al. Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:242–249.
   PubMed Web of Science ®Google Scholar
• van Gelderen CJ, Gomes dos Santos ML. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. J Reprod Med. 1993;38(5):381–386.
   PubMed Web of Science ®Google Scholar
• Rojansky N, Roll D, Meirow D. Polycystic ovary syndrome. An autoimmune disease? J Reprod Med. 1997;42:325–328.
   PubMed Web of Science ®Google Scholar
• Luborsky JL, Shatavi S, Adamczyk P, et al. Polycystic ovary syndrome and ovarian autoimmunity-assessment of ovarian antibodies by EIA. J Reprod Immunol. 1999;42:79–84.
   PubMed Web of Science ®Google Scholar
• Haller K, Mathieu C, Rull K, et al. IgG, IgA and IgM antibodies against FSH: serological markers of pathogenic autoimmunity or of normal immunoregulation? Am J Reprod Immunol. 2005;54:262–269.
   PubMed Web of Science ®Google Scholar
• Janssen OE, Mehlmauer N, Hahn S, et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol. 2004;150:363–369.
   PubMed Web of Science ®Google Scholar
• Lee S-H, Kim M-R, Kim J-H, et al. A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2. Gynecol Endocrinol off J Int Soc Gynecol Endocrinol. 2007;23:252–256.
   PubMed Web of Science ®Google Scholar
• Hamedi B, Sarvestani EK, Khalili A, et al. Evaluation of ANA-related serologic autoantibodies in polycystic ovary syndrome. Immunol Endocr Metab Agents Med Chem. 2014;14:21–25.
   Google Scholar
• Lahita RG. Gender disparity in systemic lupus erythematosus, thoughts after the 8th International Congress on Systemic Lupus Erythematosus, Shanghai, China, 2007. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2008;14:185–187.
   Google Scholar
• Angstwurm MW, Gärtner R, Ziegler-Heitbrock HW. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine. 1997;9:370–374.
   PubMed Web of Science ®Google Scholar